Literature DB >> 18628222

Beneficial response to macrolide antibiotic in a patient with desquamative interstitial pneumonia refractory to corticosteroid therapy.

Alexey Knyazhitskiy1, Richard G Masson, Richard Corkey, Jane Joiner.   

Abstract

Macrolide antibiotics have been shown to have a beneficial effect in a number of pulmonary conditions that are characterized by inflammation, including cystic fibrosis, asthma, and cryptogenic organizing pneumonia. We report the first case of desquamative interstitial pneumonia (DIP) showing a favorable response to treatment with clarithromycin. If confirmed, this observation would add DIP to the list of pulmonary disorders that are amenable to the beneficial antiinflammatory effects of macrolides.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628222     DOI: 10.1378/chest.07-2786

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

Review 1.  Interstitial lung diseases in children.

Authors:  Annick Clement; Nadia Nathan; Ralph Epaud; Brigitte Fauroux; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2010-08-20       Impact factor: 4.123

2.  Desquamative interstitial pneumonitis in a patient with systemic lupus erythematosus.

Authors:  Faranak Esmaeilbeigi; Stephen Juvet; David Hwang; Shikha Mittoo
Journal:  Can Respir J       Date:  2012 Jan-Feb       Impact factor: 2.409

Review 3.  Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects.

Authors:  Hiroshi Kitazawa; Shigeo Kure
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.